Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide

CHEBI:CHEBI_751986

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

active_ingredient_name
TENOFOVIR ALAFENAMIDE
rxcui
2049677
product_type
DRUG FOR FURTHER PROCESSING
marketing_category
DRUG FOR FURTHER PROCESSING
listing_expiration_date
20251231
route
ORAL
dosage_form
TABLET, FILM COATED
pharm_class_moa
HIV Protease Inhibitors [MoA]
pharm_class
Protease Inhibitor [EPC]
active_ingredient_strength
200 mg/1
nui
N0000175889
marketing_start_date
20180717
package_marketing_start_date
17-JUL-18
unii
EL9943AG5J
pharm_class_epc
Protease Inhibitor [EPC]
pharm_class_cs
Nucleosides [CS]
labeler_name
Janssen Products LP
manufacturer_name
Janssen Products LP
generic_name
Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide
brand_name
Symtuza
brand_name_base
Symtuza
product_ndc
63285-816
application_number
NDA210455
spl_id
bc375a32-5ca2-4604-8253-9f2313f844cf
package_ndc
63285-816-00
package_description
6262 TABLET, FILM COATED in 1 DRUM (63285-816-00)
spl_set_id
85a17d00-6b7c-41ea-a6b3-5ad924820dab
upc
0359676800309
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class